Gabelli Funds LLC trimmed its stake in shares of Cigna Group (NYSE:CI – Free Report) by 5.2% during the third quarter, HoldingsChannel reports. The fund owned 64,620 shares of the health services provider’s stock after selling 3,510 shares during the quarter. Gabelli Funds LLC’s holdings in Cigna Group were worth $18,627,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Gamco Investors INC. ET AL raised its stake in shares of Cigna Group by 0.4% in the 3rd quarter. Gamco Investors INC. ET AL now owns 13,395 shares of the health services provider’s stock valued at $3,861,000 after purchasing an additional 58 shares in the last quarter. GABELLI & Co INVESTMENT ADVISERS INC. grew its stake in Cigna Group by 22.2% in the third quarter. GABELLI & Co INVESTMENT ADVISERS INC. now owns 1,100 shares of the health services provider’s stock worth $317,000 after purchasing an additional 200 shares in the last quarter. Aptus Capital Advisors LLC grew its stake in Cigna Group by 100.3% in the third quarter. Aptus Capital Advisors LLC now owns 4,889 shares of the health services provider’s stock worth $1,409,000 after purchasing an additional 2,448 shares in the last quarter. Longfellow Investment Management Co. LLC increased its holdings in Cigna Group by 69.2% in the third quarter. Longfellow Investment Management Co. LLC now owns 2,447 shares of the health services provider’s stock valued at $705,000 after buying an additional 1,001 shares during the last quarter. Finally, Pitcairn Co. increased its holdings in Cigna Group by 2.3% in the third quarter. Pitcairn Co. now owns 2,099 shares of the health services provider’s stock valued at $605,000 after buying an additional 47 shares during the last quarter. Institutional investors own 86.99% of the company’s stock.
Cigna Group Trading Down 3.5%
NYSE:CI opened at $271.50 on Friday. The firm has a market capitalization of $71.55 billion, a P/E ratio of 12.24, a P/E/G ratio of 0.94 and a beta of 0.27. The business has a 50 day simple moving average of $280.71 and a 200 day simple moving average of $284.11. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.74. Cigna Group has a 12-month low of $239.51 and a 12-month high of $350.00.
Cigna Group Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Investors of record on Thursday, March 5th will be given a $1.56 dividend. The ex-dividend date is Thursday, March 5th. This represents a $6.24 annualized dividend and a yield of 2.3%. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s payout ratio is 28.13%.
Analyst Ratings Changes
CI has been the subject of several research reports. UBS Group reiterated a “buy” rating and issued a $375.00 target price on shares of Cigna Group in a research report on Monday, February 9th. Mizuho set a $325.00 price objective on Cigna Group in a research note on Friday, January 9th. TD Cowen lifted their price objective on shares of Cigna Group from $333.00 to $338.00 and gave the stock a “buy” rating in a report on Monday, February 9th. Truist Financial boosted their target price on shares of Cigna Group from $320.00 to $350.00 and gave the company a “buy” rating in a research note on Tuesday, February 17th. Finally, Wall Street Zen raised shares of Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. One analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $330.42.
Get Our Latest Research Report on Cigna Group
Insider Transactions at Cigna Group
In other Cigna Group news, insider Everett Neville sold 1,719 shares of the company’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $496,636.29. Following the completion of the transaction, the insider owned 5,670 shares in the company, valued at approximately $1,638,119.70. This represents a 23.26% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Nicole S. Jones sold 2,307 shares of the firm’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the sale, the insider owned 32,647 shares in the company, valued at $9,432,044.77. The trade was a 6.60% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.70% of the company’s stock.
Cigna Group Company Profile
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Further Reading
- Five stocks we like better than Cigna Group
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Trump Planning to Use Public Law 63-43: Prepare Now
- How JPMorgan’s $8,000 Gold Call Will Leave Most Retirement Accounts Behind
- Silver Is the New Oil—And the World’s Running Dry
- Nvidia CEO Issues Bold Tesla Call
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
